Interferon-alpha, you can fully epidemic type I
diabetes

Read The Full Article:
http://feedproxy.google.com/~r/DailyMedicalNews/~3/07KMUDVndjc/interferon-alpha-y
ou-can-fully-epidemic.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

Bowel cancer: Researchers identify genetic
markers for metastasis formation

Read The Full Article:
http://feedproxy.google.com/~r/DailyMedicalNews/~3/Bp-17r0AA9k/bowel-cancer-resea
rchers-identify.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

New treatment for back gently gums: no pain, more
profit

Read The Full Article:
http://feedproxy.google.com/~r/DailyMedicalNews/~3/0qBex8-x_ug/new-treatment-for-
back-gently-gums-no.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

New Idea on how the brain stem cells to grow
cells, repair damaged tissue

Read The Full Article:
http://feedproxy.google.com/~r/DailyMedicalNews/~3/clGg5AXV0HQ/new-idea-on-how-br
ain-stem-cells-to.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

Better diet helps diabetes

Read The Full Article:
http://feedproxy.google.com/~r/DailyMedicalNews/~3/MoMgmGMmELg/better-diet-helps-
diabetes.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

Clinical Trial Update On Therapeutic Effects Of
Combined Treatment With Ribavirin And Tiazofurin

2 - Jul- 2009
Hard To Treat Diseases (HTDS) Chief Scientist with its Slavica BioChem subsidiary, Dr. Sanja Pekovic provided updates on recent clinical trials with animal subjects in regards to the use of Ribavirin And Tiazofurin for the potential treatment of Multiple Sclerosis (MS).

Dr. Pekovic reported; "It is now well accepted that axonal injury begins at an early stage in MS, and likely accounts for clinical progression seen later in the disease course, suggesting that early, aggressive treatment is critical in order to suppress long-term disability progression. Researchers from IBISS group (a related research group) tested the effect of combined treatment with ribavirin (R) and tiazofurin (T) administrated during the effecter phase of disease.

Read More
====================

Keep Current with MS information by registering at our website http://www.msviewsandnews.org - After registering you will begin receiving the weekly MS e-Newsletter called "Stu's Views and MS Related News".This weekly publication is being received in (48) countries.If not yet receiving this, join now, to not miss another issue. - thank you

Read The Full Article:
http://wwwmsviewsandrelatednews.blogspot.com/2009/07/clinical-trial-update-on-the
rapeutic.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

UCB And Biogen Idec Discontinue Phase II Clinical
Trial Of CDP323 - Analysis Showed No Clinically Relevant Benefit For Patients

July 2, 2009
UCB and Biogen Idec announced today the discontinuation of the Phase II clinical trial of CDP323 for the treatment of relapsing multiple sclerosis (MS). Preliminary interim efficacy analysis showed that patients enrolled in this clinical trial did not benefit as expected from CDP323 compared to placebo after a six month treatment period. No cases of PML (progressive multifocal leukoencephalopathy) were noted.

CDP323 is an oral small molecule alpha4 integrin inhibitor that was being developed by UCB and Biogen Idec for relapsing forms of multiple sclerosis.

Read More
============================================

Read The Full Article:
http://wwwmsviewsandrelatednews.blogspot.com/2009/07/ucb-and-biogen-idec-disconti
nue-phase.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

MS related : Sex and Intimacy - Learn Online

MS Learn Online Presents
Today's new Feature Presentation
Sex and Intimacy featuring Rosalind Kalb, PhD focuses on:

• Sexual dysfunction
• Management strategies
• Improving intimacy

Click here to view the webcast, or copy into your browser: http://www.nationalmssociety.org/multimedia-library/webcasts--podcasts/sex-and-intimacy/index.aspx If you have a pop-up blocker, you will need to disable it prior to participating in a MS Learn Online webcast.

<><><><><><><><><><><><><><><>

Keep Current with MS information by registering at our website http://www.msviewsandnews.org - After registering you will begin receiving the weekly MS e-Newsletter called "Stu's Views and MS Related News". This weekly publication is being received in (48) countries.If not yet receiving this, join now, to not miss another issue. - thank you

Read The Full Article:
http://wwwmsviewsandrelatednews.blogspot.com/2009/07/ms-related-sex-and-intimacy-
learn.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

Low Dose Naltrexone info for those with MS

Information provided by Sammy Jo in Washington...

Stanford released positive results from their fibromyalgia trial in April 09 and are starting phase 2. They are alos initiating LDN research for Gulf War Syndrome.
Stanford pilot results: Low-Dose Naltrexone Reduces the Symptoms of Fibromyalgia - April 2009
Interview with Stanford researchers TV News Report WWLTV

Stanford also received patient funding for this research, similar to the LD-MS trial at UCSF in 2006 which was funded by patients. There is also news this week from Penn State that an MS patient who got great results from LDN donated $50,000 to their MS research, and a Parkinson's patient donated $75,000 to their LDN for PD research as well.
SammyJo
LDNers.org
.
Have something to share with others? If so, please use the post comment link found below. Your name and email address would be appreciated but is not necessary unless you want a response from others. Thank You
============================================

Read The Full Article:
http://wwwmsviewsandrelatednews.blogspot.com/2009/07/low-dose-naltrexone-info-for
-those-with.html

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!

Improve your beer IQ

Becoming a professional brewmaster is a lengthy and difficult process. That said, you can easily become your own beer expert and impress your friends, colleagues and family with your beer knowledge by following the advice of Molson brewmaster Ian Douglas, who says the first step to improving your beer IQ is to learn the four main characteristics that distinguish one beer from the next:

Appearance

Easily determined by looking at the beer, the foam (or head) should be compact and creamy. It should be white and cling to the glass as the beer is consumed. The head should also remain on the beer for several minutes. A poor head will collapse rapidly back into the beer. The ideal head on a beer is two to three fingers in depth.

Aroma

Aroma is a major characteristic of flavour and should be sampled repeatedly. To assess a beer’s aroma, begin by swirling your glass to release its scents. Then place your nose into the glass and take a few quick sniffs. Look for hoppy, malty, fruity and freshness notes in the aroma.

Mouth-feel

Not all aspects of flavour can be attributed to aroma and taste. Mouth-feel describes the tactile impressions of smoothness, body (thin or heavy), bite and warming. To evaluate mouth-feel, take a sip of beer and move it around your mouth with your tongue, then swallow it. Look for body, carbonation, mouth coating and smoothness.

Taste

Taste is the most crucial aspect of beer evaluation and also the most personal. Take a healthy sip of beer and allow it to run around your tongue and the inside of your mouth, then swallow it. Notice if the beer is malty, sweet, mellow or slightly astringent. Also look for a hoppy tang and a touch of bitterness. Does the flavour of the beer linger or disappear quickly? Repeat the process, each time concentrating on a different aspect of the beer. Remember: there are no rights or wrongs in beer tasting.

- News Canada

Read The Full Article:
http://nafwa.org/blog/?p=434

Add to del.icio.us   Digg this   Post to Furl   Add to reddit   Add to myYahoo!